Acupuncture Treatment of Guillain-Barre Syndrome After Using Immune Checkpoint Inhibitors: A Case Report.
Ontology highlight
ABSTRACT: Guillain-Barré syndrome(GBS) is an autoimmune-mediated peripheral neuropathy. Immune checkpoint inhibitors (ICIs) are the standard treatment for cancer and may lead to immune-related adverse events (irAEs) such as GBS. Corticosteroids, plasma exchange (PE), and intravenous immunoglobulin (IVIG) are currently accepted treatments for ICI-induced GBS. However, there are still adverse reactions, and the effect of relieving symptoms is not as good as expected. Safe and effective complementary replacement therapy to alleviate GBS symptoms and ameliorate the quality of life is urgently required. In this case, a 63-year-old man received ICI therapy and antitumor chemotherapy for lung malignancy. After two courses of treatment, the patient gradually developed limb weakness, numbness, and pain at th
SUBMITTER: Li J
PROVIDER: S-EPMC9201402 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA